Table 1.

Average Annual Incidence, Average Annual Percentage Change in Incidence, and Case-fatality Ratios for Invasive Haemophilus influenzae Serotype a Disease, by Age Group—United States and Alaska, 2008–2017

Age (Years)United StatesAlaska
Estimated Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %
<11.60 (1.46–1.75)14.6 (11.4–17.8)6.224.73 (16.30–36.00) 1.2 (−11.2 to 15.3)7.4
1–4.41 (.36–.45)5.6 (2.8–8.5)1.14.14 (2.45–6.54)17.7 (−.8 to 39.5)11.1
5–17.03 (.03–.03)7.8 (2.0–14.0)5.0.07 (.00–.41)−1.0 (−29.8 to 39.5)a0.0
18–34.02 (.01–.02)16.4 (8.3–25.1)14.3.00 (.00–.00)0.0
35–49.05 (.04–.05)4.0 (−.1 to 8.3)11.1.07 (.00–.41)0.0
50–64.10 (.10–.11)23.4 (19.5–27.3)7.9.07 (.00–.41)0.0
≥65.14 (.14–.15)7.9 (5.0–10.9)15.1.15 (.00–.85)100.0
Total.10 (.10–.10)11.1 (9.7–12.6)7.8.68 (.50–.89)4.9 (−5.0 to 15.8)10.2
Age (Years)United StatesAlaska
Estimated Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %
<11.60 (1.46–1.75)14.6 (11.4–17.8)6.224.73 (16.30–36.00) 1.2 (−11.2 to 15.3)7.4
1–4.41 (.36–.45)5.6 (2.8–8.5)1.14.14 (2.45–6.54)17.7 (−.8 to 39.5)11.1
5–17.03 (.03–.03)7.8 (2.0–14.0)5.0.07 (.00–.41)−1.0 (−29.8 to 39.5)a0.0
18–34.02 (.01–.02)16.4 (8.3–25.1)14.3.00 (.00–.00)0.0
35–49.05 (.04–.05)4.0 (−.1 to 8.3)11.1.07 (.00–.41)0.0
50–64.10 (.10–.11)23.4 (19.5–27.3)7.9.07 (.00–.41)0.0
≥65.14 (.14–.15)7.9 (5.0–10.9)15.1.15 (.00–.85)100.0
Total.10 (.10–.10)11.1 (9.7–12.6)7.8.68 (.50–.89)4.9 (−5.0 to 15.8)10.2

Note: Incidence is presented in cases per 100 000 persons per year.

Abbreviations: CFR, case-fatality ratio; CI, confidence interval.

aDue to small numbers, age groups were combined. This average annual percentage change in incidence is for persons aged ≥5 years in Alaska.

Table 1.

Average Annual Incidence, Average Annual Percentage Change in Incidence, and Case-fatality Ratios for Invasive Haemophilus influenzae Serotype a Disease, by Age Group—United States and Alaska, 2008–2017

Age (Years)United StatesAlaska
Estimated Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %
<11.60 (1.46–1.75)14.6 (11.4–17.8)6.224.73 (16.30–36.00) 1.2 (−11.2 to 15.3)7.4
1–4.41 (.36–.45)5.6 (2.8–8.5)1.14.14 (2.45–6.54)17.7 (−.8 to 39.5)11.1
5–17.03 (.03–.03)7.8 (2.0–14.0)5.0.07 (.00–.41)−1.0 (−29.8 to 39.5)a0.0
18–34.02 (.01–.02)16.4 (8.3–25.1)14.3.00 (.00–.00)0.0
35–49.05 (.04–.05)4.0 (−.1 to 8.3)11.1.07 (.00–.41)0.0
50–64.10 (.10–.11)23.4 (19.5–27.3)7.9.07 (.00–.41)0.0
≥65.14 (.14–.15)7.9 (5.0–10.9)15.1.15 (.00–.85)100.0
Total.10 (.10–.10)11.1 (9.7–12.6)7.8.68 (.50–.89)4.9 (−5.0 to 15.8)10.2
Age (Years)United StatesAlaska
Estimated Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %Incidence (95% CI)Average Annual Percentage Change in Incidence (95% CI)CFR, %
<11.60 (1.46–1.75)14.6 (11.4–17.8)6.224.73 (16.30–36.00) 1.2 (−11.2 to 15.3)7.4
1–4.41 (.36–.45)5.6 (2.8–8.5)1.14.14 (2.45–6.54)17.7 (−.8 to 39.5)11.1
5–17.03 (.03–.03)7.8 (2.0–14.0)5.0.07 (.00–.41)−1.0 (−29.8 to 39.5)a0.0
18–34.02 (.01–.02)16.4 (8.3–25.1)14.3.00 (.00–.00)0.0
35–49.05 (.04–.05)4.0 (−.1 to 8.3)11.1.07 (.00–.41)0.0
50–64.10 (.10–.11)23.4 (19.5–27.3)7.9.07 (.00–.41)0.0
≥65.14 (.14–.15)7.9 (5.0–10.9)15.1.15 (.00–.85)100.0
Total.10 (.10–.10)11.1 (9.7–12.6)7.8.68 (.50–.89)4.9 (−5.0 to 15.8)10.2

Note: Incidence is presented in cases per 100 000 persons per year.

Abbreviations: CFR, case-fatality ratio; CI, confidence interval.

aDue to small numbers, age groups were combined. This average annual percentage change in incidence is for persons aged ≥5 years in Alaska.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close